MUR vs REGN · P/E 60, rev $3.03B vs P/E 14, rev $14.34B
Murphy Oil Corporation (MUR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Murphy Oil Corporation (MUR) is a oil & gas e&p company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MUR revenue for 2024-12-31 was $3.03B. Net income was $64.4M. MUR currently screens at market cap $5.06B and trailing P/E 59.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MUR currently screens at market cap $5.06B and trailing P/E 59.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MUR and REGN stock pages for the full models.
Not investment advice.